A phase I study of YHI-1001 in patients with solid tumors

Trial Profile

A phase I study of YHI-1001 in patients with solid tumors

Completed
Phase of Trial: Phase I

Latest Information Update: 07 Jun 2016

At a glance

  • Drugs Resminostat (Primary)
  • Indications Solid tumours
  • Focus Adverse reactions
  • Sponsors Yakult Honsha
  • Most Recent Events

    • 06 May 2014 Status changed from recruiting to completed according to a 4SC media release.
    • 13 Jul 2012 New trial record
    • 15 May 2012 The first patient has been treated, according to a media release from 4SC.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top